ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

RICARDO MARTINEZ

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

41,674Medicare Part D Prescriptions Filled, Including Refills

Rank: 26 out of 3647

$706K Total Retail Price of All Prescriptions

Rank: 545 out of 3647

1,810 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 1,810 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

5% of this provider’s 41,021 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$17 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 2,942 2,902 1 1
RENAL CAPS 1,941 1,939 10 2 119
OMEPRAZOLE 1,745 1,728 3 3
ATENOLOL 1,552 1,543 10 4 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 1,169 1,152 10 5 36
ALPRAZOLAM 1,153 1,143 6 31
LISINOPRIL 1,054 1,020 7 4
GLYBURIDE 845 845 R 10 8 54
FAMOTIDINE 842 831 9 61
AMLODIPINE BESYLATE 798 797 10 2
LEVOXYL 738 738 11 125
METOPROLOL TARTRATE 735 731 12 7
FUROSEMIDE 655 650 13 8
RANITIDINE HCL 652 643 14 29
TEMAZEPAM 648 640 15 47
SYNTHROID 636 622 16 42
FOLIC ACID 633 624 17 95
VIAGRA 580 579 18 69
GLYBURIDE-METFORMIN HCL 549 540 R 19 94
LOSARTAN POTASSIUM 540 540 20 11
VITAMIN D2 503 482 21 100
LORATADINE 503 493 21 109
LOSARTAN-HYDROCHLOROTHIAZIDE 474 463 23 48
ALENDRONATE SODIUM 449 449 24 23
ALLOPURINOL 449 449 24 37
METFORMIN HCL 427 401 26 6
HYDROCHLOROTHIAZIDE 404 400 27 9
DOXAZOSIN MESYLATE 390 390 28 57
TAMSULOSIN HCL 385 378 29 28
DONEPEZIL HCL 383 383 30 30
IBUPROFEN 376 363 31 55
VYTORIN 371 360 10 32 191
DILTIAZEM 24HR ER 347 347 10 33 164
CARVEDILOL 345 345 34 20
ENALAPRIL MALEATE 342 342 35 35
VOLTAREN 333 325 36 102
SERTRALINE HCL 323 319 37 27
MI ACID 314 308 10 38 263
LORAZEPAM 310 305 39 73
ATORVASTATIN CALCIUM 298 272 40 13
FINASTERIDE 295 295 41 66
CLOPIDOGREL 290 284 42 26
METOPROLOL SUCCINATE 290 286 42 18
WARFARIN SODIUM 269 267 44 15
ZOLPIDEM TARTRATE 258 255 45 14
AMMONIUM LACTATE 249 244 46 141
CLOTRIMAZOLE-BETAMETHASONE 241 227 47 84
MELOXICAM 235 229 48 33
CIALIS 226 207 49 179
LOVASTATIN 225 208 50 21
DIPYRIDAMOLE 220 219 R 51 500
GABAPENTIN 212 212 52 17
LIDODERM 208 197 53 108
PANTOPRAZOLE SODIUM 194 188 54 38
CICLOPIROX 174 174 55 176
PLAVIX 173 173 56 39
GEMFIBROZIL 171 166 57 82
FELODIPINE ER 165 165 58 186
ISOSORBIDE MONONITRATE ER 156 156 59 56
PROCTOZONE-HC 154 153 60 216
CITALOPRAM HBR 141 141 61 25
JALYN 141 141 61 332
LANOXIN 139 139 63 231
NAPROXEN 130 129 64 70
SURE COMFORT 125 121 65 161
PANCRELIPASE 5,000 125 120 10 65 392
BENICAR 123 123 67 114
SINGULAIR 121 121 68 90
LANTUS SOLOSTAR 119 110 69 124
TERAZOSIN HCL 118 118 70 103
DETROL LA 116 116 71 292
PAROXETINE HCL 115 104 72 60
CLONIDINE HCL 114 114 73 46
CLONAZEPAM 111 111 74 146
VENTOLIN HFA 108 107 75 88
DICLOFENAC SODIUM 107 107 76 86
PROMETHAZINE-CODEINE 104 104 R 10 77 368
FLUTICASONE PROPIONATE 103 102 78 32
NIFEDIPINE ER 96 96 79 67
NYSTATIN 95 93 80 195
AVODART 95 95 80 173
CLORAZEPATE DIPOTASSIUM 95 95 80 200
KETOCONAZOLE 94 94 83 132
ADVAIR DISKUS 94 94 83 52
AFEDITAB CR 93 93 85 237
CIPROFLOXACIN HCL 93 89 85 53
NAMENDA 85 85 87 49
CILOSTAZOL 83 83 88 168
AMLODIPINE BESYLATE-BENAZEPRIL 78 78 89 74
AZITHROMYCIN 77 72 90 34
JANUVIA 77 76 90 72
CARBIDOPA-LEVODOPA 77 77 90 127
BENICAR HCT 75 75 93 165
PREDNISONE 75 75 93 43
MUPIROCIN 72 72 95 137
NOVOLOG MIX 70-30 72 72 95 261
PENTOXIFYLLINE 71 70 97 180
NEXIUM 70 70 98 44
MONTELUKAST SODIUM 69 69 99 160
ANASTROZOLE 66 66 100 344
VESICARE 64 64 101 209
HYDROCODONE-ACETAMINOPHEN 63 58 S3 102 12
CETIRIZINE HCL 62 57 103 213
KLOR-CON M20 61 61 104 121
ROBAFEN-DM CLEAR 61 61 104 248
FENOFIBRATE 59 47 106 50
SPIRONOLACTONE 59 59 106 77
AMITRIPTYLINE HCL 59 59 R 106 105
NITROSTAT 59 56 106 206
LEVOTHYROXINE SODIUM 58 48 110 5
PROPRANOLOL HCL 58 58 110 156
LANSOPRAZOLE 58 58 110 116
IBANDRONATE SODIUM 57 57 113 276
ULTICARE 57 56 113 387
TRIAMCINOLONE ACETONIDE 54 53 115 136
GLIPIZIDE 54 53 115 41
QVAR 52 52 117 294
FLUNISOLIDE 51 51 118 284
OXYBUTYNIN CHLORIDE 51 51 118 107
RENO CAPS 50 50 10 120 564
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.